Developing Validated Assays for Biomarkers and Antibody Drug Conjugates

Friday, 25 May 2018 at 09:10

Add to Calendar ▼2018-05-25 09:10:002018-05-25 10:10:00Europe/LondonDeveloping Validated Assays for Biomarkers and Antibody Drug ConjugatesBiomarkers - From Research To Commercialization in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com

Kalpesh Jain, Founder and Technical Head, KRISHGEN Biosystems

Kalpesh Jain

Dr Kalpesh Jain, is the founder and technical head of KRISHGEN Biosystems. He has been instrumental in getting the company to move from being a distributor to one of the leading providers of bioassay kits and tools for the biopharma industry in India and internationally.
His team today works amongst other things on bioassays for large molecules for PK and Immunogenicity. Internationally, KRISHGEN todays boasts of users including Bristol Myers Squibbs, USA; National Institute of Healthh, USA and leading institutes in India including AIIMS Delhi, NIPER Chandigarh, in India. Reliance Life Sciences, Mumbai has just published a paper on a DCGI clinical trial for Adalimumab Injection marketed by them using kits provided by Krishgen.
Today, he speaks on ELISAs in the background of Biomarkers and Antibody Drug Conjugates and the do’s and dont’s of developing these assays.